Shinpoong Pharmaceutical Co Ltd (019175.KS)
Shinpoong Pharmaceutical Co.,Ltd, together with its subsidiaries, manufactures and sells pharmaceutical products in South Korea. The company offers cephalosporin antibiotics; penicillin antibiotics; and finished products, as well as antivirals, anticancer drugs, painkillers, anti-inflammatory products, and anthelmintics. It provides active pharmaceutical ingredients; Pyramax, an anti-malarial drug; and drugs for treating hypercholesterolemia, knee osteoarthritis and shoulder periarthritis, and surgical adhesion barrier; prescription drugs; wound dressings; health functional food; and over the counter products. In addition, the company engages in business management and exports its products to approximately 50 countries. The company was founded in 1962 and is headquartered in Seoul, South Korea.
Company Info
Highlights
₩580.91B
₩222.50B
₩83.57B
₩9,650.00 - ₩32,800.00
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
Loading data...
Returns By Period
Shinpoong Pharmaceutical Co Ltd (019175.KS) returned 66.24% year-to-date (YTD) and 22.25% over the past 12 months. Over the past 10 years, 019175.KS delivered an annualized return of 19.89%, outperforming the S&P 500 benchmark at 10.85%.
019175.KS
66.24%
112.71%
46.46%
22.25%
-20.78%
-7.46%
19.89%
^GSPC (Benchmark)
0.51%
5.49%
-2.00%
12.02%
12.68%
14.19%
10.85%
Monthly Returns
The table below presents the monthly returns of 019175.KS, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 2.99% | -16.57% | -15.42% | 7.54% | 112.71% | 66.24% | |||||||
| 2024 | -10.41% | 3.78% | 52.08% | -11.64% | -17.25% | -6.42% | -0.95% | 7.12% | -6.60% | -1.26% | -8.85% | -11.90% | -23.97% |
| 2023 | -3.25% | -8.71% | -15.26% | -0.96% | -3.25% | -2.85% | 12.95% | -10.55% | -14.87% | -28.55% | 7.87% | 7.61% | -50.30% |
| 2022 | -15.37% | 61.00% | 44.77% | -35.36% | 2.94% | -23.81% | 13.63% | -5.61% | -26.81% | 6.21% | 24.44% | 0.12% | 3.88% |
| 2021 | -33.96% | 4.94% | 0.12% | -14.24% | 6.04% | 75.29% | -37.12% | 17.25% | -19.32% | -15.63% | -40.44% | -0.95% | -67.25% |
| 2020 | 7.21% | 79.19% | 64.19% | 71.01% | 20.06% | 21.24% | 241.88% | 9.69% | -5.13% | -16.82% | 5.42% | -16.01% | 1,957.43% |
| 2019 | 10.34% | 4.61% | -9.84% | 18.89% | -14.38% | 0.32% | -4.31% | -13.17% | 8.25% | 4.26% | -0.17% | 1.53% | 1.02% |
| 2018 | 10.33% | 7.14% | -0.90% | 0.36% | 26.81% | 12.86% | -7.72% | 6.45% | 3.99% | -25.40% | 14.45% | -14.37% | 25.67% |
| 2017 | -4.08% | 12.11% | 2.53% | 3.03% | 5.11% | -0.83% | -8.77% | 6.18% | -6.14% | -2.41% | 21.65% | -9.19% | 16.07% |
| 2016 | 23.12% | -11.18% | 4.28% | 9.45% | 7.95% | -0.95% | -6.59% | 0.80% | -2.14% | -5.31% | 4.75% | -5.93% | 14.75% |
| 2015 | 1.52% | 4.50% | 6.06% | 13.08% | 3.46% | 11.05% | -4.86% | -12.53% | -6.82% | 4.78% | 5.27% | -4.60% | 19.29% |
| 2014 | -7.78% | 9.98% | 1.72% | -3.08% | 0.63% | -2.52% | -2.43% | 4.98% | -4.42% | -2.81% | 10.03% | -0.96% | 1.72% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of 019175.KS is 60, indicating average performance compared to other stocks on our website. Here’s a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Shinpoong Pharmaceutical Co Ltd (019175.KS) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Loading data...
Dividends
Dividend History
Shinpoong Pharmaceutical Co Ltd provided a 0.00% dividend yield over the last twelve months, with an annual payout of ₩0.00 per share.
| Period | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩115.00 | ₩115.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩62.50 |
Dividend yield | 0.00% | 0.00% | 0.00% | 0.00% | 0.29% | 0.09% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 2.12% |
Monthly Dividends
The table displays the monthly dividend distributions for Shinpoong Pharmaceutical Co Ltd. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | |||||||
| 2024 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 |
| 2023 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 |
| 2022 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 |
| 2021 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩115.00 | ₩115.00 |
| 2020 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩115.00 | ₩115.00 |
| 2019 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 |
| 2018 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 |
| 2017 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 |
| 2016 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 |
| 2015 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 |
| 2014 | ₩62.50 | ₩62.50 |
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading data...
Worst Drawdowns
The table below displays the maximum drawdowns of the Shinpoong Pharmaceutical Co Ltd. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Shinpoong Pharmaceutical Co Ltd was 97.59%, occurring on Nov 5, 1998. Recovery took 751 trading sessions.
The current Shinpoong Pharmaceutical Co Ltd drawdown is 89.24%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -97.59% | Dec 13, 1995 | 342 | Nov 5, 1998 | 751 | Mar 21, 2002 | 1093 |
| -95.86% | Sep 7, 2020 | 1123 | Apr 9, 2025 | — | — | — |
| -73.45% | Sep 25, 2002 | 112 | Mar 7, 2003 | 1209 | Aug 10, 2010 | 1321 |
| -63.68% | Mar 25, 2002 | 64 | Jun 26, 2002 | 55 | Sep 16, 2002 | 119 |
| -55.78% | Jul 7, 2015 | 33 | Aug 21, 2015 | 672 | May 18, 2018 | 705 |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading data...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Shinpoong Pharmaceutical Co Ltd over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Earnings Per Share
The chart presents the Earnings Per Share (EPS) performance of Shinpoong Pharmaceutical Co Ltd, comparing actual results with analytics estimates.
Valuation
The Valuation section provides an overview of how Shinpoong Pharmaceutical Co Ltd is priced in the market compared to other companies in the Drug Manufacturers - Specialty & Generic industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for 019175.KS relative to other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, 019175.KS has a P/S ratio of 2.6. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for 019175.KS in comparison with other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, 019175.KS has a P/B value of 5.3. This P/B ratio is higher than most companies in the industry. It may suggest the stock is overvalued or that investors expect the company to generate high returns on its assets.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |